Logo

Hemorrhage Cochrane Pediatric Emergency Medicine Reviews

Browse Cochrane Pediatric Emergency Medicine Reviews
Browse Cochrane Pediatric Emergency Medicine Reviews

Cochrane Systematic Review: Vitamin K prior to preterm birth for preventing neonatal periventricular haemorrhage

Cochrane Systematic Review: Vitamin K prior to preterm birth for preventing neonatal periventricular haemorrhage

Visit

Crowther CA, Crosby DD, Henderson-Smart DJ

Crowther CA, Crosby DD, Henderson-Smart DJ

OBJECTIVES: The objective of this review was to assess the effects of vitamin K administered to women at risk of imminent very preterm birth to prevent periventricular haemorrhage and associated neurological injury in the infant.

OBJECTIVES: The objective of this review was to assess the effects of vitamin K administered to women at risk of imminent very preterm birth to prevent periventricular haemorrhage and associated neurological injury in the infant.

Cochrane Systematic Review: Antifibrinolytic drugs for acute traumatic injury

Cochrane Systematic Review: Antifibrinolytic drugs for acute traumatic injury

Visit

Roberts I, Shakur H, Ker K, Coats T; CRASH-2 Trial collaborators

Roberts I, Shakur H, Ker K, Coats T; CRASH-2 Trial collaborators

OBJECTIVES: To quantify the effects of antifibrinolytic drugs on mortality, vascular occlusive events, surgical intervention and receipt of blood transfusion after acute traumatic injury.

OBJECTIVES: To quantify the effects of antifibrinolytic drugs on mortality, vascular occlusive events, surgical intervention and receipt of blood transfusion after acute traumatic injury.

Cochrane Systematic Review: Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia

Cochrane Systematic Review: Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia

Visit

Simpson E, Lin Y, Stanworth S, Birchall J, Doree C, Hyde C

Simpson E, Lin Y, Stanworth S, Birchall J, Doree C, Hyde C

OBJECTIVES: To assess the effectiveness of rFVIIa when used therapeutically to control active bleeding or prophylactically to prevent (excessive) bleeding in patients without haemophilia.

OBJECTIVES: To assess the effectiveness of rFVIIa when used therapeutically to control active bleeding or prophylactically to prevent (excessive) bleeding in patients without haemophilia.

Cochrane Systematic Review: Vitamin K prior to preterm birth for preventing neonatal periventricular haemorrhage

Cochrane Systematic Review: Vitamin K prior to preterm birth for preventing neonatal periventricular haemorrhage

Visit

Crowther CA, Crosby DD, Henderson-Smart DJ

Crowther CA, Crosby DD, Henderson-Smart DJ

OBJECTIVES: The objective of this review was to assess the effects of vitamin K administered to women at risk of imminent very preterm birth to prevent periventricular haemorrhage and associated neurological injury in the infant.

OBJECTIVES: The objective of this review was to assess the effects of vitamin K administered to women at risk of imminent very preterm birth to prevent periventricular haemorrhage and associated neurological injury in the infant.

Cochrane Systematic Review: Antifibrinolytic drugs for acute traumatic injury

Cochrane Systematic Review: Antifibrinolytic drugs for acute traumatic injury

Visit

Roberts I, Shakur H, Ker K, Coats T; CRASH-2 Trial collaborators

Roberts I, Shakur H, Ker K, Coats T; CRASH-2 Trial collaborators

OBJECTIVES: To quantify the effects of antifibrinolytic drugs on mortality, vascular occlusive events, surgical intervention and receipt of blood transfusion after acute traumatic injury.

OBJECTIVES: To quantify the effects of antifibrinolytic drugs on mortality, vascular occlusive events, surgical intervention and receipt of blood transfusion after acute traumatic injury.

Cochrane Systematic Review: Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia

Cochrane Systematic Review: Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia

Visit

Simpson E, Lin Y, Stanworth S, Birchall J, Doree C, Hyde C

Simpson E, Lin Y, Stanworth S, Birchall J, Doree C, Hyde C

OBJECTIVES: To assess the effectiveness of rFVIIa when used therapeutically to control active bleeding or prophylactically to prevent (excessive) bleeding in patients without haemophilia.

OBJECTIVES: To assess the effectiveness of rFVIIa when used therapeutically to control active bleeding or prophylactically to prevent (excessive) bleeding in patients without haemophilia.